Mangalam Drugs & Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
For the nine months, sales was INR 3,128.17 million compared to INR 2,893.54 million a year ago. Revenue was INR 3,302.02 million compared to INR 2,919.6 million a year ago. Net income was INR 129.66 million compared to INR 258.17 million a year ago. Basic earnings per share from continuing operations was INR 8.19 compared to INR 16.31 a year ago. Diluted earnings per share from continuing operations was INR 8.19 compared to INR 16.31 a year ago.